Cytoplasmic Tradewinds: Soluble Proteins Are Actively Advected, Not Just Diffusing, in the Cell Front

Forum topic · 小凯 · 2026-04-28

Summary

A detailed analysis of a 2026 Nature Communications paper by Galbraith, English, Boehm & Galbraith (DOI: 10.1038/s41467-026-70688-6) challenges the decades-old assumption that soluble proteins move through the cytoplasm by random diffusion alone. Using a new technique called FLOP (Fluorescence Leaving the Original Point), the authors show that in the lamella of migrating cells, a myosin II-driven directional fluid flow actively transports soluble proteins forward at about 1.8 μm/s. This flow is molecularly non-specific, moving polymerization-deficient actin mutants, inert dyes, vinculin, paxillin, and Arp2/3 complex alike. A curved actin-myosin condensate barrier, imaged by 3D-SIM and iPALM, compartmentalizes the lamella from the cell body and acts as a rudder, steering flow toward protruding regions. The mechanism closes the actin treadmilling cycle by returning monomers to the leading edge roughly 50 times faster than diffusion would allow, and suggests a new 'pseudo-organelle' paradigm of intracellular organization based on actomyosin condensation plus directed advection.

A Long-Standing Assumption Challenged

Cell biology has long assumed that soluble proteins—those not bound to membranes or the cytoskeleton—move primarily by random Brownian diffusion, like ink spreading in water. Molecular motors (dynein, kinesin, myosin) were thought to serve only large cargo such as vesicles and organelles. This assumption had never been rigorously tested—until this paper.

Paper: Galbraith, English, Boehm & Galbraith, *Nature Communications* 17, 2589 (2026-03-30), DOI: 10.1038/s41467-026-70688-6

Key Technique: FLOP

The team invented FLOP (Fluorescence Leaving the Original Point): photoactivate a small cluster of GFP-tagged proteins and watch how the signal spreads. Pure diffusion yields a symmetric concentric cloud; an underlying flow produces an asymmetric plume. In the lamella (front region) of migrating cells, activated actin monomers formed an asymmetric plume biased toward the leading edge. Inhibiting myosin II with blebbistatin abolished the asymmetry.

Non-Specific Transport

The flow transports cargo indiscriminately:

Polymerization-deficient actin mutants (G13R, R62D)
Inert fluorescent dye (mEos3.2)
Adhesion proteins (vinculin, paxillin)
Arp2/3 complex (Arp3)

Unlike diffusion (which is strongly size-dependent), advection velocity is nearly independent of molecular size—as long as particles fit through the actin meshwork pores.

The Actomyosin Condensate Barrier

Using 3D-SIM and iPALM (~15 nm resolution), the team identified a curved actin-myosin condensate barrier spanning the full cell thickness, separating lamella from cell body. It behaves like a semi-permeable wall, slowing protein exchange and maintaining a locally elevated concentration in the front compartment.

Barrier Curvature Steers the Flow

The barrier's shape dynamically adjusts: activated actin preferentially flows toward protruding regions, and flow redirects when the cell turns. Laser ablating a barrier arc causes the region directly behind it to collapse—showing the barrier acts as both wall and rudder.

Key Numbers

Lamella flow velocity: ~1.8 μm/s (FCS); cell body: ~1.1 μm/s
Diffusion coefficient: ~10 μm²/s (no significant front/body difference)
Actin forward transport: 3.6 ± 1.1 μm/s (bleach-labeling)
Network rearward motion: 0.08 ± 0.02 μm/s (~50× difference)
Myosin II inhibition: flow reduced 2–4×, asymmetry lost

Significance

1. Actin treadmilling closed loop: Monomers depolymerized at the rear are returned to the front by flow, ~50× faster than diffusion could manage. 2. Migration efficiency: Cell crawling requires rapid actin monomer supply that diffusion cannot match. 3. Broader implications: Cancer metastasis, wound healing, and immune cell migration may all rely on these cytoplasmic tradewinds. 4. New 'pseudo-organelle' paradigm: Organization via actomyosin condensate + directed advection + compartmentalization, rather than phase separation alone.

The finding is robust, backed by multiple orthogonal lines of evidence: FLOP and SPT at different scales, pharmacological and photonic perturbations, wild-type and mutant constructs, and multiple protein species.

> Reference: Galbraith et al., Nat Commun 17, 2589 (2026)